In September 2019, the FDA reported that a cancer-causing chemical was detected in several brand-name and generic heartburn medications, most prominently Zantac. Soon after this, class-action lawsuits appeared claiming that the plaintiffs’ stomach and bladder cancers were caused by Zantac and that the drug’s manufacturer knew about the presence of a carcinogen in their product.
If you or a loved one has taken Zantac or its generic equivalents and developed stomach or bladder cancer, the attorneys at Shaw Cowart, LLP will help you fight for justice. We understand how difficult and painful a cancer diagnosis can be. If the illness was caused by the negligence of a powerful pharmaceutical corporation, you may feel powerless against them.
Shaw Cowart, LLP has a track record of success in class-action lawsuits. We have also successfully pursued claims for defective drugs. Our attorneys will diligently investigate your claim and doggedly fight to help get you the compensation you deserve.
Shaw Cowart, LLP serves Austin and nearby areas of Texas. Call (512) 499-8900 today to schedule a consultation.
What Carcinogens Are in Zantac?
In September 2019, the FDA announced that amounts of the cancer-causing chemical NDMA had been detected in ranitidine, the heartburn medication sold under the brand name Zantac. NDMA is a B2 carcinogen, meaning it is a probable carcinogen in humans. It is known to cause gastric and colorectal cancers.
NDMA was once used to make rocket fuel. Now it is used for research purposes, and it is also a byproduct of pesticide and rubber manufacturing. The levels of NDMA found in Zantac are 26,000 times the FDA-approved limit.
After the FDA reported that it discovered the carcinogen NDMA in ranitidine, Sanofi, the manufacturer of Zantac, announced a recall of the medicine. CVS and Wal-Mart stopped selling Zantac, with CVS offering refunds.
The FDA is continuing to investigate the health risks of the NDMA levels in ranitidine. In the meantime, heartburn and gastric distress patients may want to consider switching to a different medication, such as cimetidine (Tagamet) or famotidine (Pepcid).
NDMA has been a known carcinogen for decades and has been labeled as such by the World Health Organization and the Environmental Protection Agency for more than 40 years. Since Zantac hit the market, studies have demonstrated that ranitidine forms NDMA when mixed with drinking water.
Despite all this evidence, Sanofi, the maker of Zantac, never publicly disclosed the risk that the drug posed. Sanofi’s concealing the presence of NDMA in ranitidine helped Zantac become the first prescription drug to reach $1 billion in sales.
Contact Our Austin Drug Litigation Attorneys Today
At Shaw Cowart, LLP, we will fight for justice on your behalf if you or a loved one developed stomach or bladder cancer after taking Zantac. No amount of money can restore your health or bring back a lost loved one, but we are committed to helping you recover the compensation you deserve. We believe that pharmaceutical companies should be held accountable for valuing profits over lives.
Shaw Cowart, LLP serves Austin and surrounding areas of Texas. Call (512) 499-8900 today to schedule a consultation.